apixaban

Poland

Drugs containing this active substance

  • PRUBDAQ

    Prubdaq is used in adults to prevent blood clots in the heart (in cases of irregular heartbeat) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary blood vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee surgery, to prevent heart clots in patients with irregular heart rhythm, and to treat deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Actavis Group PTC ehf. Actavis International Ltd. Balkanpharma-Dupnitsa AD Teva Pharma B.V.

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in patients with atrial fibrillation and additional risk) and for the treatment and prevention of recurrence of clots in the veins of the lower limbs and in the blood vessels of the lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Actavis Group PTC ehf. Actavis International Ltd. Balkanpharma-Dupnitsa AD Teva Pharma B.V.

  • The medicine is used in adults to prevent the formation of blood clots (e.g., after hip or knee surgery and in people with atrial fibrillation) and to treat thrombosis of the leg veins and pulmonary vessels. It is also used in children and adolescents for the treatment and prevention of clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in people with atrial fibrillation) and in the treatment and prevention of recurrence of clots in the veins of the legs or pulmonary vessels. In children and adolescents (from 28 days to 18 years), it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent blood clots after hip or knee surgery, to prevent clots in the heart in people with irregular heartbeat, and to treat and prevent the recurrence of blood clots in the leg veins or pulmonary vessels. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Farmak International Sp. z o.o.

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in people with an irregular heartbeat) and for the treatment and prevention of clots in the veins of the legs and pulmonary blood vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Farmak International Sp. z o.o.